Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 4Withdrawn 1Unknown 1Not yet recruiting 1Enrolling by invitation 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Multiple Myeloma 8Neoplasms, Plasma Cell 2Lymphoma 2Immunoglobulin Light-chain Amyloidosis 2Hematologic Neoplasms 2Smoldering Multiple Myeloma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Paraproteinemias 1Neoplasms 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, B-Cell 1Leukemia, Myeloid, Acute 1Leukemia, B-Cell 1Cytokine Release Syndrome 1Anemia, Sickle Cell 1Amyloid Neuropathies, Familial 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Cytokine Release Syndrome × Plasma cell × Clear all
NCT07499128 2026-06-01

Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event

National Institutes of Health Clinical Center (CC)

Phase NA Enrolling by invitation
136 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Cytokine Release Syndrome, Lymphoma, Multiple Myeloma, Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡